- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
National Comprehensive Cancer Network Guideline Updates From the 15th Annual Congress
Credits: 1.0 contact hours (0.10 CEUs)
Anthony Elias, MD, Professor of Medicine, Medical Director, Breast Cancer and Sarcoma Programs, University of Colorado Cancer Center
Educational Objectives
After completing this activity, participants should be able to:
- List some of the major National Comprehensive Cancer Network (NCCN) practice guideline revisions presented at the 15th Annual Congress
- Identify select NCCN guideline revisions that may impact the course of treatment in a given case
- Discuss the use of patient characteristics to determine therapeutic management in select NCCN guideline revisions
Target Audience: Pharmacy directors/administrators, clinical pharmacists practicing in managed care environments, and any other pharmacist practitioners involved in the care of patients diagnosed with cancer.
Strategies Needed to Address Physical Activity Before, After CVD Events
August 1st 2025Black women had lower moderate-to-vigorous intensity physical activity scores when compared with Black and White men and their White female counterparts, highlighting the need for support across patient subgroups.
Read More
Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells
August 1st 2025Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
Read More
